81 related articles for article (PubMed ID: 11236631)
1. [The cloning and expression of soluble HLA-B27 gene].
Huang F; Zhang J; Yu D
Zhonghua Yi Xue Za Zhi; 2000 Dec; 80(12):924-7. PubMed ID: 11236631
[TBL] [Abstract][Full Text] [Related]
2. The amino acid at position 97 is involved in folding and surface expression of HLA-B27.
Blanco-Gelaz MA; Suárez-Alvarez B; González S; López-Vázquez A; Martínez-Borra J; López-Larrea C
Int Immunol; 2006 Jan; 18(1):211-20. PubMed ID: 16361312
[TBL] [Abstract][Full Text] [Related]
3. Defective costimulatory function is a striking feature of antigen-presenting cells in an HLA-B27-transgenic rat model of spondylarthropathy.
Hacquard-Bouder C; Falgarone G; Bosquet A; Smaoui F; Monnet D; Ittah M; Breban M
Arthritis Rheum; 2004 May; 50(5):1624-35. PubMed ID: 15146433
[TBL] [Abstract][Full Text] [Related]
4. Enhanced intracellular replication of Salmonella enteritidis in HLA-B27-expressing human monocytic cells: dependency on glutamic acid at position 45 in the B pocket of HLA-B27.
Penttinen MA; Heiskanen KM; Mohapatra R; DeLay ML; Colbert RA; Sistonen L; Granfors K
Arthritis Rheum; 2004 Jul; 50(7):2255-63. PubMed ID: 15248225
[TBL] [Abstract][Full Text] [Related]
5. The genetically-engineered secretory B27/Q10 chimeric molecule inhibits HLA-B27 restricted alloreactive T-lymphocytes.
Kuipers JG; Bialowons A; Dollmann P; Jendro MC; Wagener N; Rebmann V; Ikeda M; Huang F; Grosse-Wilde H; Yu DT; Zeidler H; Märker-Hermann E
Clin Exp Rheumatol; 2002; 20(4):455-62. PubMed ID: 12175099
[TBL] [Abstract][Full Text] [Related]
6. HLA-B27 does not affect invasion of arthritogenic bacteria into human cells.
Ortiz-Alvarez O; Yu DT; Petty RE; Finlay BB
J Rheumatol; 1998 Sep; 25(9):1765-71. PubMed ID: 9733458
[TBL] [Abstract][Full Text] [Related]
7. Evidence that the p38 MAP kinase pathway is dysregulated in HLA-B27-expressing human monocytic cells: correlation with HLA-B27 misfolding.
Sahlberg AS; Penttinen MA; Heiskanen KM; Colbert RA; Sistonen L; Granfors K
Arthritis Rheum; 2007 Aug; 56(8):2652-62. PubMed ID: 17665421
[TBL] [Abstract][Full Text] [Related]
8. Identification of cytokines that might enhance the promoter activity of HLA-B27.
Zhao L; Fong Y; Granfors K; Gu J; Yu D
J Rheumatol; 2008 May; 35(5):862-8. PubMed ID: 18381783
[TBL] [Abstract][Full Text] [Related]
9. Quantitative measurement of HLA-B27 mRNA in patients with ankylosing spondylitis-- correlation with clinical activity.
Liu SQ; Yu HC; Gong YZ; Lai NS
J Rheumatol; 2006 Jun; 33(6):1128-32. PubMed ID: 16755659
[TBL] [Abstract][Full Text] [Related]
10. HLA-B27 transgenic rats model.
Breban M
Ann Med Interne (Paris); 1998 Apr; 149(3):139-41. PubMed ID: 11490535
[TBL] [Abstract][Full Text] [Related]
11. Induction of alternative splicing of HLA-B27 by bacterial invasion.
Huang F; Yamaguchi A; Tsuchiya N; Ikawa T; Tamura N; Virtala MM; Granfors K; Yasaei P; Yu DT
Arthritis Rheum; 1997 Apr; 40(4):694-703. PubMed ID: 9125251
[TBL] [Abstract][Full Text] [Related]
12. Additional human beta2-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats.
Tran TM; Dorris ML; Satumtira N; Richardson JA; Hammer RE; Shang J; Taurog JD
Arthritis Rheum; 2006 Apr; 54(4):1317-27. PubMed ID: 16575857
[TBL] [Abstract][Full Text] [Related]
13. The HLA-B27 transgenic rat, a model of spondyloarthritis, has decreased bone mineral density and increased RANKL to osteoprotegerin mRNA ratio.
Rauner M; Stupphann D; Haas M; Fert I; Glatigny S; Sipos W; Breban M; Pietschmann P
J Rheumatol; 2009 Jan; 36(1):120-6. PubMed ID: 19040304
[TBL] [Abstract][Full Text] [Related]
14. Discrimination of HLA null and low expression alleles by cytokine-induced secretion of recombinant soluble HLA.
Hinrichs J; Figueiredo C; Hirv K; Mytilineos J; Blasczyk R; Horn PA; Eiz-Vesper B
Mol Immunol; 2009 Apr; 46(7):1451-7. PubMed ID: 19195705
[TBL] [Abstract][Full Text] [Related]
15. Alteration of antigen-independent immunologic synapse formation between dendritic cells from HLA-B27-transgenic rats and CD4+ T cells: selective impairment of costimulatory molecule engagement by mature HLA-B27.
Hacquard-Bouder C; Chimenti MS; Giquel B; Donnadieu E; Fert I; Schmitt A; André C; Breban M
Arthritis Rheum; 2007 May; 56(5):1478-89. PubMed ID: 17469106
[TBL] [Abstract][Full Text] [Related]
16. Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia: implications for disease pathogenesis.
Fiorillo MT; Cauli A; Carcassi C; Bitti PP; Vacca A; Passiu G; Bettosini F; Mathieu A; Sorrentino R
Arthritis Rheum; 2003 May; 48(5):1385-9. PubMed ID: 12746911
[TBL] [Abstract][Full Text] [Related]
17. HLA-B27 has no effect on the phenotypic expression of progressive ankylosis in ank/ank mice.
Krug HE; Taurog JD
J Rheumatol; 2000 May; 27(5):1257-9. PubMed ID: 10813297
[TBL] [Abstract][Full Text] [Related]
18. Does HLA-B27 influence the monocyte inflammatory response to lipopolysaccharide?
Goodall JC; Ellis L; Yeo GS; Gaston JS
Rheumatology (Oxford); 2007 Feb; 46(2):232-7. PubMed ID: 16877465
[TBL] [Abstract][Full Text] [Related]
19. Similar cell surface expression of beta2-microglobulin-free heavy chains by HLA-B27 subtypes differentially associated with ankylosing spondylitis.
Vázquez MN; López de Castro JA
Arthritis Rheum; 2005 Oct; 52(10):3290-9. PubMed ID: 16200602
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of Disease: the immunopathogenesis of spondyloarthropathies.
Gaston H
Nat Clin Pract Rheumatol; 2006 Jul; 2(7):383-92. PubMed ID: 16932724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
